2005
Glucose-mediated DNA Damage and Mutations: In Vitro and In Vivo
Lee A, Cerami A, Bucala R. Glucose-mediated DNA Damage and Mutations: In Vitro and In Vivo. 2005, 249-253. DOI: 10.1533/9781845698393.4.249.Peer-Reviewed Original ResearchEukaryotic model systemsMammalian systemsTransgenic embryosTransgenic miceSignificant genetic alterationsDNA mutationsDNA damageBiological integrityGenetic alterationsMaternal environmentMutation frequencyModel systemNucleic acidsMutationsVitroVivoFunctional activityLacI.Nonenzymatic glycosylationEmbryosGlycosylationLacI mutation frequencyDNAComparative analysisMiceA NOVEL AGE CROSSLINK EXHIBITING IMMUNOLOGICAL CROSS-REACTIVITY WITH AGES FORMED IN VIVO
Al-Abed Y, Bucala R. A NOVEL AGE CROSSLINK EXHIBITING IMMUNOLOGICAL CROSS-REACTIVITY WITH AGES FORMED IN VIVO. 2005, 239-244. DOI: 10.1533/9781845698447.7.239.Peer-Reviewed Original Research
2001
Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo
Hartlapp I, Abe R, Saeed R, Peng T, Voelter W, Bucala R, Metz C. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. The FASEB Journal 2001, 15: 2215-2224. PMID: 11641248, DOI: 10.1096/fj.01-0049com.Peer-Reviewed Original ResearchConceptsBlood vessel formationAngiogenic phenotypeVessel formationMesenchymal cell typesEndothelial cell invasionEndothelial cellsExtracellular matrix-degrading enzymesEndothelial cell migrationGrowth factorCellular microenvironmentMatrix-degrading enzymesCell invasionCell migrationCell typesCultured endothelial cellsTube formationHematopoietic growth factorsPromotion of angiogenesisPhenotypeAngiogenesis modelMicrovascular endothelial cellsCultured fibrocytesEnzymeAngiogenesisVivo
1999
Structure of a Synthetic Glucose Derived Advanced Glycation End Product That Is Immunologically Cross-Reactive with Its Naturally Occurring Counterparts †
Al-Abed Y, Bucala R. Structure of a Synthetic Glucose Derived Advanced Glycation End Product That Is Immunologically Cross-Reactive with Its Naturally Occurring Counterparts †. Bioconjugate Chemistry 1999, 11: 39-45. PMID: 10639083, DOI: 10.1021/bc990061q.Peer-Reviewed Original ResearchConceptsAdvanced glycation end productsAnti-AGE antibodyGlycation end productsLow-density lipoproteinAGE-modified formCertain diabetic complicationsClasses of antibodiesBeta-amyloid peptideDiabetic complicationsPathological sequelaePrognostic informationAGE formationAGE adductsImmunoreactive fractionEnd productsInhibition of formationVivo ageAgeAntibodiesLines of evidenceVivoCross-linking adductsGlucoseTissueComplications
1997
Efficient Scavenging of Fatty Acid Oxidation Products by Aminoguanidine
Al-Abed Y, Bucala R. Efficient Scavenging of Fatty Acid Oxidation Products by Aminoguanidine. Chemical Research In Toxicology 1997, 10: 875-879. PMID: 9282836, DOI: 10.1021/tx970035l.Peer-Reviewed Original ResearchConceptsLow-density lipoprotein levelsAdvanced glycation end productsGlycation end productsMechanism of actionVascular wall componentsLipoprotein levelsLipoprotein metabolismOxidative stressPharmacological inhibitorsFatty acid oxidation productsHuman subjectsToxic effectsAminoguanidineOxidative damageNormal pathwayReactive aldehydesRecent studiesPotential interactionsDamaging effectsVivoTissue constituentsEnd productsAtherogenesisLipid oxidationMalondialdehyde
1992
Advanced Glycosylation: Chemistry, Biology, and Implications for Diabetes and Aging
Bucala R, Cerami A. Advanced Glycosylation: Chemistry, Biology, and Implications for Diabetes and Aging. Advances In Pharmacology 1992, 23: 1-34. PMID: 1540533, DOI: 10.1016/s1054-3589(08)60961-8.Peer-Reviewed Original ResearchConceptsBiological processesGlycosylation processGlycosylation mechanismsBiochemical basisRelated pathwaysAge-related processesBiologyPathological processesGlycosylation productsDiverse effectsStructural elucidationAdvanced glycosylation productsCell-mediated processGlycosylationInsightsPathwayBiochemistryElucidationMaillard reactionAccumulationVivoLarge partMultiorgan pathology